Project Grant R01CA297856

Award Date 9/15/24
Completion Date 8/31/28
Dollars Obligated $141K
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This $175,000 project grant, awarded by the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070), aims to develop efficient interpretation and explanation techniques for advanced AI systems, particularly in critical healthcare applications. The research objectives are to: 1) accelerate computationally intensive explainable AI algorithms, 2) construct unified explainer models for efficient generation of explanations, and 3) validate the...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Yale University totals $167,500 and will be executed from September 2023 through August 2025. The primary objectives are to: Develop deep neural network-based emulation analysis methods and software to objectively quantify the relative effectiveness of drugs, devices, and treatment procedures on cancer prognosis, especially when randomized clinical trials are not feasible. The...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Sloan-Kettering Institute for Cancer Research provides $700,611 to conduct a randomized controlled trial (RCT) evaluating the use of artificial intelligence (AI) to assist dermatologists in diagnosing melanoma. The project aims to determine the potential benefits and barriers to adopting AI technology, as well as assess its impact on reducing the number of unnecessary...
This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an AI-powered system to enhance the detection and tracking of metastatic colorectal cancer using computed tomography (CT) imaging. The $718,456 award, with a project period from July 1, 2025 to May 31, 2029, will enable researchers at the...
This Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $1,199,514 to develop a comprehensive and scalable multimodal AI model, termed "PRECISE", that fuses imaging and non-imaging data to enable early detection of pancreatic ductal adenocarcinoma (PDAC). The project aims to create deep learning models that can segment imaging biomarkers from abdominal CT scans and combine them with clinical data...
This $435,827 Project Grant from the National Cancer Institute (NCI) under the CFDA 93.394 Cancer Detection and Diagnosis Research program supports research conducted by New York University (NYU) School of Medicine to develop deep learning methods for analyzing mass spectrometry imaging (MSI) data. The goal is to make MSI data more accessible to existing machine learning workflows by expanding the dimensionality of the data structure to treat each metabolite or lipid as an individual "color...
This $989,122 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to evaluate the performance of four commercial mammography-based artificial intelligence (AI) algorithms for breast cancer risk prediction in diverse U.S. screening populations. The project will assess the accuracy and equity of these AI risk models compared to traditional clinical risk factor-based models, using data from the Breast Cancer...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to DePaul University totaling $406,204 supports the development and validation of a novel Semantic Deep-Learning Neural Network (SDNN) model. The goal is to create an explainable and accurate Computer-Aided Diagnosis (CAD) mechanism that can establish a common understanding between CAD systems and radiologists on visually important diagnostic patterns for lung nodules. The...
The National Cancer Institute (NCI) awarded a $570,634 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to the University of Connecticut to develop a robust, multimodal, and longitudinal artificial intelligence (AI) system to enhance breast cancer screening. The overarching objective is to optimize and personalize breast cancer screening by advancing AI algorithms that can transform clinical decision-making. The key products/services to be delivered...
The National Cancer Institute (NCI) awarded a $680,433 Project Grant under CFDA 93.394 - Cancer Detection and Diagnosis Research to The Regents of the University of California, San Francisco (UCSF) to conduct a multi-year research project titled "Multimodality Spatial Analysis in Prostate Cancer to Improve Prognostic Estimation and Cast Light into the Black Box of Pathology Artificial Intelligence Algorithms." The goal of this research is to apply cutting-edge spatial proteogenomic...

This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Emory University for $140,511 supports the development of a computational framework that leverages AI visual explanation to guide AI-based abdominal cancer diagnostic imaging. The key objectives are to: 1) Improve AI sample efficiency through visual explanation supervision of cancer imaging annotations, 2) Consolidate AI's knowledge across multi-institutional data while preserving privacy, and 3) Prompt AI prediction with human explanation and accelerate AI training using AI-guided explanation annotation. This project aims to reduce overdiagnosis and unnecessary monitoring, especially in high-risk groups, while providing open-source tools and datasets to enhance AI explainability, applicability, and human-AI collaboration in abdominal cancer diagnostics. The award period runs from September 15, 2024 to August 31, 2028.

Generated 7/1/25, 3:24 AM